Encouraging Efficacy and Safety: CStone Presents Latest Clinical Data on CS5001 for Advanced Lymphoma at the 66th ASH Annual Meeting CS5001 is so far the first anti-ROR1 ADC known to show clinical anti-tumor… CISION PRNewswireDecember 9, 2024
Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients with Advanced Pancreatic Cancer at the ESMO Asia Congress 2024 SAN FRANCISCO and SUZHOU, China, Dec. 9, 2024 /PRNewswire/ — Innovent Biologics,… CISION PRNewswireDecember 9, 2024
WTCH 24 – Countless historical results and a new superpower emerged BUDAPEST, Hungary, Dec. 9, 2024 /PRNewswire/ — Every World Teqball Championships is unique… CISION PRNewswireDecember 9, 2024
Press ReleaseRiyadh Action Agenda Gathers Steam as Land Governance Takes Center Stage at UNCCD COP16 RIYADH, Saudi Arabia, Dec. 8, 2024 /PRNewswire/ — The role of governance… CISION PRNewswireDecember 8, 2024
Press ReleaseRiyadh International Philosophy Conference 2024 Concludes with a Focus on Quality of Life Day 3 explored the philosophical contributions to the quality of life, and… CISION PRNewswireDecember 8, 2024
Press ReleaseNanning: A Colorful City of Cultural Diversity BEIJING, Dec. 8, 2024 /PRNewswire/ — A report from China Daily: Gen… CISION PRNewswireDecember 8, 2024
The Best Christmas Gift Ideas for 2024: Transformative Skincare with a Special Holiday Twist PLEASANTON, Calif., Dec. 8, 2024 /PRNewswire/ — This holiday season, DermRays invites you to… CISION PRNewswireDecember 8, 2024
CCTV+: Yuhang Journey ǀ Follow Olivier to Explore Ancient Liangzhu and Savor Jingshan Tea BEIJING, Dec. 8, 2024 /PRNewswire/ — "Hello everyone, this is Laolu…" Olivier, a… CISION PRNewswireDecember 8, 2024
